StockData
GeneDx Holdings Corp. logo

GeneDx Holdings Corp. (WGS) bonds

WGSNasdaqServices-Health ServicesFiscal year ends December 31
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Nov 9, 2026Score 6/3058% above fair value
$51.96+4.67 (+9.88%)

Close on Nov 18, 2026Market cap $1.55BP/E –Yield –

Debt

Borrowings on the balance sheet, Jun 30, 2026

Total debt
$96.84M
$0 due within a year
Net debt
$36.52M
After $60.32M of cash
Implied interest rate
–
FY2025 interest ÷ average debt
Interest coverage
–
FY2025 operating income ÷ interest

Total debt by fiscal year

Long-term plus current debt, USD

When the debt comes due

Principal repayments of long-term debt by fiscal year, as scheduled at Dec 31, 2025

From the debt maturity table in the annual report (filing). “Later” is everything due after year five.

Notes and loans outstanding

As tagged in GeneDx's 10-Q for the period ended Mar 31, 2026

IssueCouponCarrying value
DECD Loan Agreement2.00%$4.50M

Companies tag their debt differently: some list every note, others group notes by issuance year or by type, so the list may not add up to total debt. Notes that matured before today are hidden. Source: 10-Q.

Credit facilities

Revolving credit lines and other committed borrowing capacity

FacilitySize
Blackstone Loan Agreement$100.00M
Credit Agreement$75.00M
Credit Agreement, Tranche A Loan$50.00M
Credit Agreement, Tranche B Loan$25.00M

See a number that looks wrong?